Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
Notice Number: NOT-HL-10-107
Update: The following update relating to this announcement has been issued:
Release Date: May 7, 2010
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov)
The National Heart, Lung, and Blood Institute (NHLBI) intends to issue a Funding Opportunity Announcements (FOA) titled: “Blood and Marrow Transplant Clinical Trials Network (BMT CTN) – Core Clinical Centers (U10)” . The goal of this initiative is to support a cooperative, multicenter clinical program that promotes efficient comparison of novel treatment and management approaches for the potential benefit of children and adults undergoing hematopoietic stem cell transplantation. Core Clinical Centers are expected to identify areas of scientific need, and to develop and participate in new Phase II and Phase III clinical trials designed to improve transplant outcomes and change clinical practice. The Data Coordinating Center is expected to bring scientific, technical, and administrative expertise for the full range of activities needed to support the conduct of new multicenter trials in hematopoietic stem cell transplantation. The Data Coordinating Center will manage protocol dollars for all sites enrolling subjects on BMT CTN trials.
The FOA for the Core Clinical Centers is anticipated to utilize the U10 NIH Cooperative Clinical Research Center Agreement grant mechanism. The funds awarded and the number of awards will depend on the number, quality, duration, and costs of the applications received. A companion FOA is expected to be published for Data Coordinating Center applications (see NOT-HL-10-108).
This FOA is expected to be published in the summer of 2010 with applications due in the fall of 2010.
This Notice is being provided to allow potential applicants sufficient time to develop responsive projects.
APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.
Interested parties may contact:
Nancy L. DiFronzo, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
6701 Rockledge Drive
Bethesda MD 20892-7952
Bethesda, MD 20817 (for courier service)
Roy Wu, Ph.D.
Chief, Clinical Grants and Contracts Branch
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
6130 Executive Boulevard
Bethesda, Maryland 20892
Rockville, Maryland (FEDEX) 20852
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.